Targeting cancer stem cell pathways for cancer therapy
Southwest University · State Key Laboratory of Silkworm Genomic Biology · +2 more institutions
Abstract
Since cancer stem cells (CSCs) were first identified in leukemia in 1994, they have been considered promising therapeutic targets for cancer therapy. These cells have self-renewal capacity and differentiation potential and contribute to multiple tumor malignancies, such as recurrence, metastasis, heterogeneity, multidrug resistance, and radiation resistance. The biological activities of CSCs are regulated by several pluripotent transcription factors, such as OCT4, Sox2, Nanog, KLF4, and MYC. In addition, many intracellular signaling pathways, such as Wnt, NF-κB (nuclear factor-κB), Notch, Hedgehog, JAK-STAT (Janus kinase/signal transducers and activators of transcription), PI3K/AKT/mTOR (phosphoinositide…
Citation impact
- FWCI
- 92.77
- Percentile
- 100%
- References
- 782
Authors
11- LYLiqun YangCorresponding
Southwest University, State Key Laboratory of Silkworm Genomic Biology
- PSPengfei Shi
Southwest University, State Key Laboratory of Silkworm Genomic Biology
- GZGaichao Zhao
Southwest University, State Key Laboratory of Silkworm Genomic Biology
- JXJie Xu
Southwest University, State Key Laboratory of Silkworm Genomic Biology
- WPWen Peng
Southwest University, State Key Laboratory of Silkworm Genomic Biology
Topics & keywords
- Cancer stem cell
- Cancer research
- SOX2
- Biology
- Stem cell
- Wnt signaling pathway
- Homeobox protein NANOG
- PI3K/AKT/mTOR pathway
- Good health and well-being
Funding
- NSNational Science Foundation
- NNNational Natural Science Foundation of ChinaAwards: 81872071, 81902664, 81672502
- NSNatural Science Foundation of ChongqingAwards: cstc2019jcyj, cstc2019jcyj-zdxmX0033
- NKNational Key Research and Development Program of ChinaAwards: 2017YFC1308600, 2016YFC1302204, 2016YFC1302204 and 2017YFC1308600